This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2013 Mar 20;31(9):1125-7.

doi: 10.1200/JCO.2012.46.9460. Epub 2013 Feb 19.

Off-label use of cancer drugs: a benchmark is established

Monika K Krzyzanowska

PMID: 23423744
DOI: 10.1200/JCO.2012.46.9460

Editorial

Off-label use of cancer drugs: a benchmark is established

Monika K Krzyzanowska. J Clin Oncol. 2013.

. 2013 Mar 20;31(9):1125-7.

doi: 10.1200/JCO.2012.46.9460. Epub 2013 Feb 19.

Author

Monika K Krzyzanowska

PMID: 23423744
DOI: 10.1200/JCO.2012.46.9460

No abstract available

PubMed Disclaimer

Comment on

Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologists.
Conti RM, Bernstein AC, Villaflor VM, Schilsky RL, Rosenthal MB, Bach PB. Conti RM, et al. J Clin Oncol. 2013 Mar 20;31(9):1134-9. doi: 10.1200/JCO.2012.42.7252. Epub 2013 Feb 19. J Clin Oncol. 2013. PMID: 23423747 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations